Startup Scout 13 Sep 2019 This Biotech Makes Meat Substitutes from Crops Using Fungi We’re traveling to Glasgow, UK, this week. The biotech 3F BIO is using fungi to convert plant sugars into proteins in a process that uses less than half of the water and feed that farming animal meat requires. Mission: To turn plant sugars into proteins using fungi, which could help to feed the growing world’s […] September 13, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 12 Sep 2019 French Biotech to Develop Septic Shock Therapy with €39M Series B The French company Inotrem has raised €39M to fund an immunotherapy for septic shock, an often deadly condition caused by infections in the bloodstream. Led by the Hong Kong investor Morningside Ventures, the Series B round will finance a phase IIb trial of Inotrem’s lead candidate drug nangibotide, expected to start in November this year. […] September 12, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 11 Sep 2019 Dutch Company Raises €60M to Treat Inherited Inflammatory Disease The Dutch pharmaceutical company Pharvaris has raked in €60M in a Series B round to fund the clinical development of the first oral treatment for hereditary angioedema, a condition that causes swelling in the limbs and airways. The Series B round will fuel the clinical progress of Pharvaris’ oral small molecule treatment for hereditary angioedema, […] September 11, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Sep 2019 Grünenthal to Pay up to €900M for Chronic Low Back Pain Cell Therapy The German pharmaceutical company Grünenthal has licensed a donor cell therapy for chronic low back pain from the Australian biotech Mesoblast in a deal that could be worth over €900M. Under the terms of the deal, Grünenthal will gain exclusive rights to commercialize Mesoblast’s cell therapy for chronic low back pain in Europe and Latin […] September 11, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Sep 2019 Italian Biotech Raises €13M to Test Stem Cell Therapy for Cancer The Italian biotech Genenta Science has raised €13.2M in a private round to fund two ongoing phase I/II trials of its stem cell therapy Temferon for blood and brain cancer. Genenta Science will use the money to fund two European phase I/II trials, which the company launched in March. One trial is testing the stem […] September 11, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 10 Sep 2019 Blood Test Increases Early Lung Cancer Diagnosis in UK Trial A blood test for anti-cancer antibodies, developed by the UK diagnostics company Oncimmune, detected more early cases of lung cancer than standard clinical monitoring procedures in a trial with more than 12,000 patients. Oncimmune’s trial recruited 12,209 patients with a high risk of developing lung cancer through smoking and family history, and monitored them for […] September 10, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 9 Sep 2019 4BIO Capital Raises €45M Fund to Invest in Advanced Therapies The London-based life sciences investor 4BIO Capital has raised €45M in the first close of a fund to nurture companies developing advanced therapies such as gene and cell therapies. This is the first closing of 4BIO’s second fund, called 4BIO Ventures II, which is expected to total €136M ($150M) by late 2020. The fund will […] September 9, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 6 Sep 2019 This Biotech Regenerates Bone Tissue to Treat Tooth Loss In the university town of Umeå, Sweden, the biotech company Omnio is developing treatments for tooth loss in conditions such as periodontitis. Mission: To promote wound healing by enhancing the action of plasminogen, a protein in the blood that is important in the healing process. Enhancing the action of this molecule could allow the company […] September 6, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 5 Sep 2019 Top Cardiology Biotech News from the ESC Conference 2019 Many cardiology companies and academics gathered in Paris earlier this week to showcase their latest research into cardiovascular diseases. Read on for a roundup of the most exciting cardiology news from the biotech scene. The European Society of Cardiology teamed up with the World Heart Federation this year to arrange a conference themed on global […] September 5, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 4 Sep 2019 US Genomics Firm Combines with Curetis to Tackle Antibiotic Resistance The German biotech Curetis has been combined with the US genomics company OpGen to pool their molecular diagnostics expertise in the fight against antibiotic resistance. “After more than one year of intensive discussions and negotiations for many months, it feels great to be able to announce the transaction today,” Oliver Schacht, the CEO of Curetis, […] September 4, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 4 Sep 2019 Overcoming Clinical Setbacks to Fight Insect-Borne Diseases Sometimes things don’t go your way in the biotech industry. The CEO of Valneva, Thomas Lingelbach, shared his experience of migrating from big pharma to biotech, and how his first biotech company weathered phase III failures to develop vaccines for neglected diseases. Once confined to the less developed regions of the world, many insect-borne diseases […] September 4, 2019 - 9 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 3 Sep 2019 UK Biotech’s Personalized Immunotherapy gets €110M Series B Boost The UK company Achilles Therapeutics has raised €110M (£100M) to test its personalized cancer cell immunotherapies in humans for the first time. The large Series B round will fund two phase I/IIa clinical trials of Achilles’ preclinical immunotherapy which are expected to start this year: one in non-small cell lung cancer and the other in […] September 3, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email